Gender difference in efficacy and dose response in Japanese patients with nocturia treated with four different doses of desmopressin orally disintegrating tablet in a randomized, placebo-controlled trial

BJU International

Volumn 111, Issue 3, 2013, Pages 474-484

  Yamaguchi, Osamu ^a   Nishizawa, Osamu ^b   Juul, Kristian Vinter ^c   Nørgaard, Jens Peter ^c  

^a NIHON UNIVERSITY   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c International PharmaScience Center   (Denmark)

Author keywords

desmopressin; gender difference; nocturia; nocturnal polyuria

Indexed keywords

DESMOPRESSIN; PLACEBO;

ABDOMINAL DISCOMFORT; ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CONTROLLED STUDY; COUGHING; DISINTEGRATING TABLET; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPONATREMIA; JAPANESE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MICTURITION; MULTICENTER STUDY; NOCTURIA; NOCTURIA QUALITY OF LIFE SCORE; PARALLEL DESIGN; PERIPHERAL EDEMA; PHASE 2 CLINICAL TRIAL; PITTSBURGH SLEEP QUALITY INDEX; PRIORITY JOURNAL; PULSE RATE; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; RHINOPHARYNGITIS; RISK BENEFIT ANALYSIS; SCORING SYSTEM; SEX DIFFERENCE; SIDE EFFECT; SINGLE DRUG DOSE; SODIUM BLOOD LEVEL; TABLET; THIRST; URINARY TRACT FUNCTION; URINE OSMOLALITY; UROPOIESIS; VITAL SIGN;

AGED; ANTIDIURETIC AGENTS; DEAMINO ARGININE VASOPRESSIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NOCTURIA; SEX FACTORS; TREATMENT OUTCOME;

EID: 84874664173     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11547.x     Document Type: Article

References (28)

1. Van Kerrebroeck P, Abrams P, Chaikin D, et al. The standardization of terminology in nocturia: report from the standardization subcommittee of the International Continence Society. BJU Int 2002; 90 (Suppl. 3): 11-15
2. Yoshimura K,. Correlates for nocturia: A review of epidemiological studies. Int J Urol 2012; 19: 317-329
3. Schneider T, de la Rosette JJ, Michel MC,. Nocturia: a non-specific but important symptom of urological disease. Int J Urol 2009; 16: 249-256
4. Smith AL, Wein AJ,. Outcomes of pharmacological management of nocturia with non-antidiuretic agents: does statistically significant equal clinically significant? BJU Int 2011; 107: 1550-1554
5. Yoong HF, Sundaram MB, Aida Z,. Prevalence of nocturnal polyuria in patients with benign prostatic hyperplasia. Med J Malaysia 2005; 60: 294-296
6. Weiss J,. Prevalence of nocturnal polyuria in nocturia. J Urol 2009; 181: e538 Supplement
7. Chang SC, Lin AT, Chen KK, et al. Multifactorial nature of male nocturia. Urology 2006; 67: 541-544
8. Swithinbank LV, Vestey S, Abrams P,. Nocturnal polyuria in community-dwelling women. BJU Int 2004; 93: 523-527
9. Koseoglu H, Aslan G, Ozdemir I, Esen A,. Nocturnal polyuria in patients with lower urinary tract symptoms and response to alpha-blocker therapy. Urology 2006; 67: 1188-1192
10. Asplund R, Aberg H,. Diurnal variation in the levels of antidiuretic hormone in the elderly. J Intern Med 1991; 229: 131-134
11. Matthiesen TB, Rittig S, Nørgaard JP, Pedersen EB, Djurhuus JC,. Nocturnal polyuria and natriuresis in male patients with nocturia and lower urinary tract symptoms. J Urol 1996; 156: 1292-1299
12. Bodo G, Gontero P, Casetta G, et al. Circadian antidiuretic hormone variation in elderly men complaining of persistent nocturia after urinary flow obstruction removal. Scand J Urol Nephrol 1998; 32: 320-324
13. Moon DG, Jin MH, Lee JG, Kim JJ, Kim MG, Cha DR,. Antidiuretic hormone in elderly male patients with severe nocturia: a circadian study. BJU Int 2004; 94: 571-575
14. Graugaard-Jensen C, Rittig S, Djurhuus JC,. Nocturia and circadian blood pressure profile in healthy elderly male volunteers. J Urol 2006; 176: 1034-1039
15. Natsume O,. A clinical investigation of nocturnal polyuria in patients with nocturia: a diurnal variation in arginine vasopressin secretion and its relevance to mean blood pressure. J Urol 2006; 176: 660-664
16. Van Kerrebroeck PE, Dmochowski R, FitzGerald MP, et al. Nocturia research: current status and future perspectives. Neurourol Urodyn 2010; 29: 623-628
17. Mattiasson A, Abrams P, Van Kerrebroeck P, Walter S, Weiss J,. Efficacy of desmopressin in the treatment of nocturia: a double-blind placebo-controlled study in men. BJU Int 2002; 89: 855-862
18. Lose G, Lalos O, Freeman RM. van, Kerrebroeck P,; Nocturia Study Group. Efficacy of desmopressin (Minirin) in the treatment of nocturia: a double-blind placebo-controlled study in women. Am J Obstet Gynecol 2003; 189: 1106-1113
19. Østerberg O, Balchen T, Riis A, Senderovitz T,. Pharmacokinetics of desmopressin in children and adults using a new oral lyophilisate. Arch Dis Child 2006; 91 (Suppl. I): A33
20. Committee for Establishment of the Clinical Guidelines for Nocturia of the Neurogenic Bladder Society. Clinical guidelines for nocturia. Int J Urol 2010; 17: 397-409
21. Juul KV, Klein BM, Sandström R, Erichsen L, Nørgaard JP,. Gender difference in antidiuretic response to desmopressin. Am J Physiol Renal Physiol 2011; 300: F1116-1122
22. Weiss JP, Zinner NR, Klein BM, Nørgaard JP,. Desmopressin orally disintegrating tablet effectively reduces nocturia: Results of a randomized, double-blind, placebo-controlled trial. Neurourol Urodyn 2012; 31: 441-447
23. Carrel L, Willard HF,. X-inactivation profile reveals extensive variability in x-linked gene expression in females. Nature 2005; 434: 400-404
24. Migeon B,. X Inactivation, female mosaicism, and sex differences in renal diseases. J Am Soc Nephrol 2008; 19: 2052-2059
25. Stachenfeld NS, Dipietro L, Palter SF, Nadel ER,. Estrogen influences osmotic secretion of AVP and body water balance in postmenopausal women. Am J Physiol Regul Integr Comp Physiol 1998; 274: R187-195
26. Bosch JL, Weiss JP,. The prevalence and causes of nocturia. J Urol 2010; 184: 440-446
27. Ancoli-Israel S, Bliwise DL, Nørgaard JP,. The effect of nocturia on sleep. Sleep Med Rev 2011; 15: 91-97
28. Vande Walle J, Stockner M, Raes A, Nørgaard JP,. Desmopressin 30 years in clinical use: a safety review. Curr Drug Saf 2007; 2: 232-238